Roger joined InferMed Ltd as Chairman of the Board in 2000. A seasoned IT executive Roger has over four decades of IT industry experience with the latter three decades spent in the Health IT sector specifically.
Between 1983 and 1998 Roger helped set up and manage SMS European operations and rose to become CEO of Northern Europe, UK, Ireland, Benelux. In his roles he effected organisational turnaround from a loss producing organisation to multi million profit producing organisation and established new operations/distributors in Scandinavia, Middle East and South Africa,. In addition he undertook numerous acquisitions in UK and Benelux.
Roger formed his own consulting practice in 1998 with the aim of focusing on Strategic engagements with Health IT suppliers. The company remains a very successful entity today – almost ten years after its inception. Roger is also Chairman of Stalis ltd. and of CareMax International Ltd.

Duane joined the Board of InferMed in May 2007. A business and finance graduate of the University Of Notre Dame in the U.S.A., Duane has a track record spanning almost 2 decades in healthcare solution sales and management. Prior to taking over as CEO of InferMed Duane was General Manager of Misys Healthcare Systems, International Ltd with responsibility for the company’s operations outside of North America. Based in the UK since 2003 Mr Lawrence brings with him in-depth experience in exploring and developing new markets, product management, sales & marketing, implementation and customer service components of clinically based technology solutions across both GP practice and hospital based acute care settings. Having worked with technology solutions within clinical organisations across the US, Europe, the Middle East and Asia, Duane has an experienced global view on using technology to improve patient care.

Robert Dunlop was elected as a Fellow of the Royal Australasian College of Physicians in 1986. Robert has responsibility for developing decision support applications with Arezzo. Robert has an extensive clinical background in general internal medicine and palliative care, having worked in several major London teaching hospitals and at St Christopher's Hospice. Before joining InferMed, Robert had been involved in developing knowledge bases and clinical decision support applications with the Advanced Computation Laboratory, Cancer Research UK.

Founding Director Martin Ryan’s, responsibilities include business development, financial planning and control, legal and contract issues and general administration. Martin is InferMed's Company Secretary and is an Associate of the Institute of Chartered Secretaries. At Imperial Cancer Research Technology he was involved in technology transfer, intellectual property and contract negotiation, and was responsible for company accounts. Martin joined Barclays' management development programme after graduation, becoming a Product Manager in Barclays' Electronic Banking Division.